Download PDF
Semin Reprod Med 2018; 36(01): 042-049
DOI: 10.1055/s-0038-1667308
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Evaluation of a Center of Research Excellence in Polycystic Ovary Syndrome as a Large-Scale Collaborative Research Translation Initiative, Including Evaluating Translation of Guideline Impact

Rhonda Garad
1   Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia
,
Samantha Kozica-Olenski
1   Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia
2   Internal Medicine Research Unit, The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
,
Helena J. Teede
1   Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia
3   National Health and Medical Research Council Centre for Research Excellence in PCOS, Monash and Adelaide Universities, Melbourne, Victoria, Australia
› Author Affiliations
Further Information

Publication History

Publication Date:
06 September 2018 (online)

    Permissions and Reprints

Abstract

Research translation and evaluation are often underconsidered in research design and implementation thus limiting research benefit to the end user. In this article, we first describe a best practice approach to evaluation, for a center of research excellence in polycystic ovary syndrome. Within this, we outline a comprehensive research translation program with inbuilt evaluation of the first International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2018). We seek to provide a real-world example of comprehensive approaches to evaluation and research translation.

Keywords

polycystic ovary syndrome - evaluation - research translation - best practice
 

  • References

  • 1 March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25 (02) 544-551
    CrossrefPubMedGoogle Scholar
  • 2 Boyle JA, Cunningham J, O'Dea K, Dunbar T, Norman RJ. Prevalence of polycystic ovary syndrome in a sample of indigenous women in Darwin, Australia. Med J Aust 2012; 196 (01) 62-66
    CrossrefPubMedGoogle Scholar
  • 3 Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod 2012; 27 (10) 3067-3073
    CrossrefPubMedGoogle Scholar
  • 4 Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007; 370 (9588): 685-697
    CrossrefPubMedGoogle Scholar
  • 5 Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8: 41
    CrossrefPubMedGoogle Scholar
  • 6 Dokras A, Saini S, Gibson-Helm M, Schulkin J, Cooney L, Teede H. Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome. Fertil Steril 2017; 107 (06) 1380-1386.e1
    CrossrefPubMedGoogle Scholar
  • 7 Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 2017; 32 (05) 1075-1091
    CrossrefPubMedGoogle Scholar
  • 8 Teede HJ, Misso ML, Deeks AA. , et al; Guideline Development Groups. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust 2011; 195 (06) S65-S112
    CrossrefPubMedGoogle Scholar
  • 9 Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2017; 102 (02) 604-612
    PubMedGoogle Scholar
  • 10 Boyle J, Xu R, Gilbert E. , et al. AskPCOS: Identifying need to inform evidence-based app development for polycystic ovary syndrome Semin. Reprod Med 2018; 36 (01) 64-73
    PubMedGoogle Scholar
  • 11 Misso ML, Tassone EC, Costello MF. , et al. Large scale evidence-based guideline development engaging the international PCOS community. Semin Reprod Med 2018; 36 (01) 30-36
    PubMedGoogle Scholar
  • 12 Xie J, Burstein F, Garad R, Teede H, Boyle J. Personalized mobile tool AskPCOS delivering evidence-based quality information about polycystic ovary syndrome. Semin Reprod Med 2018; 36 (01) 74-80
    PubMedGoogle Scholar
  • 13 Teede HJ, Costello MF, Dokras A. , et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018;11(03)
    PubMedGoogle Scholar
  • 14 Robinson T, Skouteris H, Melder A. , et al. Application of Monash Centre for Health Research and Implementation framework to development of PCOS guideline: a case study on implementation. Semin Reprod Med 2018; 36 (01) 13-18
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Francis LJ, Smith BJ. Toward best practice in evaluation: a study of Australian health promotion agencies. Health Promot Pract 2015; 16 (05) 715-723
    CrossrefPubMedGoogle Scholar
  • 16 Lobo R, Petrich M, Burns SK. Supporting health promotion practitioners to undertake evaluation for program development. BMC Public Health 2014; 14: 1315
    CrossrefPubMedGoogle Scholar
  • 17 Swinburn B, Bell C, King L, Magarey A, O'Brien K, Waters E. ; Primary Prevention Group of the Australian Childhood and Adolescent Obesity Research Network. Obesity prevention programs demand high-quality evaluations. Aust N Z J Public Health 2007; 31 (04) 305-307
    CrossrefPubMedGoogle Scholar
  • 18 Owen JM. Program Evaluation: Forms and Approaches. 3rd ed. New South Wales, Australia: Allen & Unwin; 2006
    Google Scholar
  • 19 Moore G, Audrey S, Barker M. , et al. Process evaluation of complex interventions: Medical Research Council guidance. British Medical Journal 2015;350(h1258)
    PubMedGoogle Scholar
  • 20 A Framework for Program Evaluation. Centers for Disease Control and Prevention. . Available at: https://www.cdc.gov/mmwr/PDF/rr/rr4811.pdf . Updated May 15, 2017. Accessed July 18, 2018
    PubMedGoogle Scholar
  • 21 Centre for Disease Control and Prevention. A Framework for Program Evaluation. Atlanta, USA. Available at: http://www.cdc.gov/eval/framework/ . Accessed August 15, 2015
    PubMedGoogle Scholar
  • 22 Lingard L, Albert M, Levinson W. Grounded theory, mixed methods, and action research. British Medical Journal 2008; 337(a567)
    PubMedGoogle Scholar
  • 23 Straus SE, Tetroe J, Graham I. Defining knowledge translation. CMAJ 2009; 181 (3-4): 165-168
    CrossrefPubMedGoogle Scholar
  • 24 Graham ID, Logan J, Harrison MB. , et al. Lost in knowledge translation: time for a map?. J Contin Educ Health Prof 2006; 26 (01) 13-24
    CrossrefPubMedGoogle Scholar
  • 25 Greenhalgh T. What is this knowledge that we seek to “exchange”?. Milbank Q 2010; 88 (04) 492-499
    CrossrefPubMedGoogle Scholar